Latest News
Hainan Poly Pharm.Co., Ltd in the 2024 DCAT Week
【INVITATION】CPHI2023 Booth No. : 2P29 --POLY PHARM
Zhejiang Poly Pharmaceutical's Eye Drop Workshop Complies with Chinese, American, and European GMP Requirements - Open to Domestic and International CDMO/CMO Collaborations
Anhui Poly Pharmaceutical's Magnesium Hydroxide API Approved for Market, with a Yearly Production Capacity of Up to 200 Tons!
Poly Pharmaceutical Obtains Market Approval for Azithromycin Injection in Israel, Further Securing Antibiotic Supply
About US
Poly Pharm., established in 1992, is a high-tech enterprise specialized in R & D, registration, manufacturing and sales of APIs, excipients and finished products for domestic and overseas markets. Poly Pharm adheres to the corporate tenet of “Good Medicine, Healthy People” and is committed to providing products and services with therapeutic values for patients and customers all over the world.
We have rich technical reserve and experience in R&D and global registration of pharmaceutical preparations. We have 3 manufacturing facilities located in Haikou, Hangzhou and Anqing respectively, with its production lines being inspected by NMAP, FDA, EMA and/or WHO for cGMP compliance, covering the dosage forms of injections, tablets, capsules, oral suspensions (granules), eye drops and ointments, as well as APIs and excipients. We have established a wide range of sales channels and diverse marketing models: the domestic marketing network has covered more than 1,000 hospitals and a number of primary medical institutions and other medical terminals in provinces, cities and autonomous regions; we also have maintained sustainable cooperation with our overseas partners and distributors, with more than 25 products being marketed in US, Germany, France, Netherlands, UK, Canada, Australia and etc.
30
Export Destinations
157
International Approvals
97
Innovative Patents
Poly Pharn
China GEM 300630
0.00 RMB
Highest
0.00
Lowest
0.00
Volume (M shares)
0.00
Turnover(100M CNY)
0.00
By